BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 29992387)

  • 1. Lung cancer screening with MRI: Evaluation of MRI for lung cancer screening by comparison of LDCT- and MRI-derived Lung-RADS categories in the first two screening rounds.
    Meier-Schroers M; Homsi R; Gieseke J; Schild HH; Thomas D
    Eur Radiol; 2019 Feb; 29(2):898-905. PubMed ID: 29992387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer screening with MRI: results of the first screening round.
    Meier-Schroers M; Homsi R; Skowasch D; Buermann J; Zipfel M; Schild HH; Thomas D
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):117-125. PubMed ID: 28932985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
    Barbosa EJM; Yang R; Hershman M
    AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.
    Li Q; Balagurunathan Y; Liu Y; Qi J; Schabath MB; Ye Z; Gillies RJ
    Clin Lung Cancer; 2018 Mar; 19(2):148-156.e3. PubMed ID: 29137847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging.
    Silvestri GA; Goldman L; Tanner NT; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Fedewa S
    Chest; 2023 Jul; 164(1):241-251. PubMed ID: 36773935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.
    Guichet PL; Liu BY; Desai B; Surani Z; Cen SY; Lee C
    AJR Am J Roentgenol; 2018 Mar; 210(3):489-496. PubMed ID: 29166147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
    Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
    Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of the PanCan Model and Lung-RADS to Assess Cancer Probability Among People With Screening-Detected, Solid Lung Nodules.
    Sundaram V; Gould MK; Nair VS
    Chest; 2021 Mar; 159(3):1273-1282. PubMed ID: 33393476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
    Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
    Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen.
    Sverzellati N; Silva M; Calareso G; Galeone C; Marchianò A; Sestini S; Sozzi G; Pastorino U
    Eur Radiol; 2016 Nov; 26(11):3821-3829. PubMed ID: 26868497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer screening with MRI: characterization of nodules with different non-enhanced MRI sequences.
    Meier-Schroers M; Homsi R; Schild HH; Thomas D
    Acta Radiol; 2019 Feb; 60(2):168-176. PubMed ID: 29792040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
    Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
    JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Lung-RADS category 4 lesions in a university lung cancer screening program.
    Kocher Wulfeck M; Plesner S; Herndon JE; Christensen JD; Patz EF
    Lung Cancer; 2023 Dec; 186():107420. PubMed ID: 37956610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Risk in Nodules Detected at Follow-Up Lung Cancer Screening CT.
    Hammer MM; Byrne SC
    AJR Am J Roentgenol; 2022 Apr; 218(4):634-641. PubMed ID: 34755524
    [No Abstract]   [Full Text] [Related]  

  • 15. Lung-RADS Category 3 and 4 Nodules on Lung Cancer Screening in Clinical Practice.
    Mendoza DP; Petranovic M; Som A; Wu MY; Park EY; Zhang EW; Archer JM; McDermott S; Khandekar M; Lanuti M; Gainor JF; Lennes IT; Shepard JO; Digumarthy SR
    AJR Am J Roentgenol; 2022 Jul; 219(1):55-65. PubMed ID: 35080453
    [No Abstract]   [Full Text] [Related]  

  • 16. Implementation of an Integrated Lung Cancer Prevention and Screening Program Using a Mobile Computed Tomography (CT) Unit in Brazil.
    Chiarantano RS; Vazquez FL; Franco A; Ferreira LC; Cristina da Costa M; Talarico T; Oliveira ÂN; Miziara JE; Mauad EC; Caetano da Silva E; Ventura LM; Junior RH; Leal LF; Reis RM
    Cancer Control; 2022; 29():10732748221121385. PubMed ID: 36204992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of lung MRI in lung cancer screening.
    Allen BD; Schiebler ML; Sommer G; Kauczor HU; Biederer J; Kruser TJ; Carr JC; Hazen G
    Eur Radiol; 2020 Mar; 30(3):1738-1746. PubMed ID: 31748855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receipt of Recommended Follow-up Care After a Positive Lung Cancer Screening Examination.
    Rivera MP; Durham DD; Long JM; Perera P; Lane L; Lamb D; Metwally E; Henderson LM
    JAMA Netw Open; 2022 Nov; 5(11):e2240403. PubMed ID: 36326760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules.
    Chung K; Jacobs C; Scholten ET; Mets OM; Dekker I; Prokop M; van Ginneken B; Schaefer-Prokop CM
    Eur Radiol; 2017 Nov; 27(11):4672-4679. PubMed ID: 28439653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Lung-Screening Reporting and Data System Versus Pan-Canadian Early Detection of Lung Cancer Nodule Risk Calculation in the Alberta Lung Cancer Screening Study.
    Tremblay A; Taghizadeh N; MacGregor JH; Armstrong G; Bristow MS; Guo LLQ; Lydell C; Pereira R; Lee A; Elliot T; MacEachern P; Graham A; Dickinson JA; Koetzler R; Lam SC; Yang H; Bédard EL; Tammemagi M; Burrowes P
    J Am Coll Radiol; 2019 Oct; 16(10):1425-1432. PubMed ID: 31103442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.